Skip to main content
A

ARGENT BIOPHARMA LIMITED — Investor Relations & Filings

Ticker · RGT ISIN · AU0000326647 LEI · 213800HRE3FQJ6RK4H10 ASX Manufacturing
Filings indexed 92 across all filing types
Latest filing 2026-04-12 Regulatory Filings
Country AU Australia
Listing ASX RGT

About ARGENT BIOPHARMA LIMITED

https://argentbiopharma.com

Argent Biopharma Limited is a biopharmaceutical company focused on the development and commercialization of innovative, plant-inspired, and synthetic medicines. The company specializes in addressing unmet medical needs within the fields of neurology and immunology. Its research and development pipeline features treatments for refractory epilepsy, dementia, and systemic inflammatory conditions. Key products include CannEpil, a phytocannabinoid-derived formulation for epilepsy, and CogniCann, aimed at improving the quality of life for patients with dementia. Additionally, the company has developed CimetrA, a nanoparticle-based treatment designed to modulate the immune system and address cytokine storms. Argent Biopharma emphasizes a data-driven approach to drug discovery, leveraging clinical research and standardized manufacturing to provide pharmaceutical-grade therapies to international markets.

Recent filings

Filing Released Lang Actions
Completion of CannPal Asset Acquisition and Neuvis Option 2 pages 495.1KB
Regulatory Filings
2026-04-12 English
Application for quotation of securities - RGT 8 pages 20.9KB
Regulatory Filings
2026-04-09 English
Application for quotation of securities - RGT 8 pages 21.4KB
Regulatory Filings
2026-04-09 English
Application for quotation of securities - RGT 8 pages 21.6KB
Regulatory Filings
2026-04-09 English
Notification regarding unquoted securities - RGT 8 pages 21.0KB
Regulatory Filings
2026-04-09 English
s708A Cleansing Notice 1 page 390.4KB
Regulatory Filings
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.